| [1] |
Ellison-Barnes A, Johnson S, Gudzune K. Trends in Obesity Prevalence Among Adults Aged 18 Through 25 Years, 1976-2018[J]. JAMA, 2021, 326(20): 2073-2074.
|
| [2] |
Abdulla M, Mohammed N, AlQamish J. Overview on the endoscopic treatment for obesity: A review[J]. World J Gastroenterol, 2023, 29(40): 5526-5542.
|
| [3] |
Collaborators GBDRF. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020, 396(10258): 1223-1249.
|
| [4] |
Perdomo CM, Cohen RV, Sumithran P, et al. Contemporary medical, device, and surgical therapies for obesity in adults[J]. Lancet, 2023, 401(10382): 1116-1130.
|
| [5] |
Look ARG, Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial[J]. Arch Intern Med, 2010, 170(17): 1566-1575.
|
| [6] |
Grunvald E, Shah R, Hernaez R, et al. AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity[J]. Gastroenterology, 2022, 163(5): 1198-1225.
|
| [7] |
Gasoyan H, Tajeu G, Halpern MT, et al. Reasons for underutilization of bariatric surgery: The role of insurance benefit design[J]. Surg Obes Relat Dis, 2019, 15(1): 146-151.
|
| [8] |
Laing P, Pham T, Taylor L J, et al. Filling the Void: A Review of Intragastric Balloons for Obesity[J]. Dig Dis Sci, 2017, 62(6): 1399-1408.
|
| [9] |
Jirapinyo P, Hadefi A, Thompson CC, et al. American Society for Gastrointestinal Endoscopy-European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity[J]. Endoscopy, 2024, 56(6): 437-456.
|
| [10] |
Kim SH, Chun HJ, Choi HS, et al. Current status of intragastric balloon for obesity treatment[J]. World J Gastroenterol, 2016, 22(24): 5495-5504.
|
| [11] |
Buzga M, Kupka T, Siroky M, et al. Short-term outcomes of the new intragastric balloon End-Ball((R)) for treatment of obesity[J]. Wideochir Inne Tech Maloinwazyjne, 2016, 11(4): 229-235.
|
| [12] |
Mechanick JI, Apovian C, Brethauer S, et al. Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures-2019 Update: Cosponsored by American Association of Clinical Endocrinologists/ American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists[J]. Obesity (Silver Spring), 2020, 28(4): O1-O58.
|
| [13] |
Bazerbachi F, Vargas EJ, Abu Dayyeh BK. Endoscopic Bariatric Therapy: A Guide to the Intragastric Balloon[J]. Am J Gastroenterol, 2019, 114(9): 1421-1431.
|
| [14] |
Dolan RD, Schulman AR. Endoscopic Approaches to Obesity Management[J]. Annu Rev Med, 2022, 73: 423-438.
|
| [15] |
Zerrweck C, Maunoury V, Caiazzo R, et al. Preoperative weight loss with intragastric balloon decreases the risk of significant adverse outcomes of laparoscopic gastric bypass in super-super obese patients[J]. Obes Surg, 2012, 22(5): 777-782.
|
| [16] |
Zurawinski W, Sokolowski D, Krupa-Kotara K, et al. Evaluation of the results of treatment of morbid obesity by the endoscopic intragastric balloon implantation method[J]. Wideochir Inne Tech Maloinwazyjne, 2017, 12(1): 37-48.
|
| [17] |
Kermansaravi M, Esparham A, Parmar C, et al. Intragastric Balloon as a Bridge Before Metabolic and Bariatric Surgery: A Systematic Review and Meta-analysis[J]. Obes Surg, 2025, 35(5): 1934-1946.
|
| [18] |
Reja D, Zhang C, Sarkar A. Endoscopic bariatrics: current therapies and future directions[J]. Transl Gastroenterol Hepatol, 2022, 7: 21.
|
| [19] |
Carrano FM, Peev MP, Saunders JK, et al. The Role of Minimally Invasive and Endoscopic Technologies in Morbid Obesity Treatment: Review and Critical Appraisal of the Current Clinical Practice[J]. Obes Surg, 2020, 30(2): 736-752.
|
| [20] |
Marinos G, Eliades C, Raman Muthusamy V, et al. Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study[J]. Surg Obes Relat Dis, 2014, 10(5): 929-934.
|
| [21] |
Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic Bariatric and Metabolic Therapies: New and Emerging Technologies[J]. Gastroenterology, 2017, 152(7): 1791-1801.
|
| [22] |
刘南, 郭瑾陶, 孙思予. 内镜技术在减重治疗中的应用进展[J]. 中国实用内科杂志, 2023, 43(1): 78-83.
|
| [23] |
刘京丽, 田沛荣, 张鹏. 内镜减重技术进展及未来趋势[J]. 中国实用外科杂志, 2023, 43(5): 583-586.
|
| [24] |
Ahmed EM. Hydrogel: Preparation, characterization, and applications: A review[J]. J Adv Res, 2015, 6(2): 105-121.
|
| [25] |
Shirin H, Richter V, Matalon S, et al. Safety, tolerability and efficacy of a novel self-use biodegradable device for management of obesity[J]. Obes Sci Pract, 2019, 5(4): 376-382.
|
| [26] |
Pass A, Bialonczyk D, Chiquette E, et al. Oral Superabsorbent Hydrogel(Plenity) for Weight Management[J]. Ann Pharmacother, 2021, 55(9): 1146-1152.
|
| [27] |
Greenway FL, Aronne LJ, Raben A, et al. A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss[J]. Obesity(Silver Spring), 2019, 27(2): 205-216.
|
| [28] |
Nduma BN, Mofor KA, Tatang J, et al. Endoscopic Sleeve Gastroplasty(ESG) Versus Laparoscopic Sleeve Gastroplasty(LSG): A Comparative Review[J]. Cureus, 2023, 15(7): e41466.
|
| [29] |
Elmaleh-Sachs A, Schwartz JL, Bramante CT, et al. Obesity Management in Adults: A Review[J]. JAMA, 2023, 330(20): 2000-2015.
|
| [30] |
卞景愿, 朱宝成, 严斌, 等. 干预胃的内镜减重现状与发展趋势[J]. 中国普外基础与临床杂志, 2024, 31(4): 403-408.
|
| [31] |
Lopez-Nava G, Sharaiha RZ, Vargas EJ, et al. Endoscopic Sleeve Gastroplasty for Obesity: a Multicenter Study of 248 Patients with 24 Months Follow-Up[J]. Obes Surg, 2017, 27(10): 2649-2655.
|
| [32] |
Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity(MERIT): a prospective, multicentre, randomised trial[J]. Lancet, 2022, 400(10350): 441-451.
|
| [33] |
范志宁, 王建坤. 内镜减重手术的现状和未来[J]. 外科理论与实践, 2018, 23(6): 502-505.
|
| [34] |
Miller K, Turro R, Greve JW, et al. MILEPOST Multicenter Randomized Controlled Trial: 12-Month Weight Loss and Satiety Outcomes After pose(SM) vs. Medical Therapy[J]. Obes Surg, 2017, 27(2): 310-322.
|
| [35] |
Sullivan S, Swain JM, Woodman G, et al. Randomized sham- controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: The ESSENTIAL trial[J]. Obesity (Silver Spring), 2017, 25(2): 294-301.
|
| [36] |
Lopez-Nava G, Asokkumar R, Turro Arau R, et al. Modified primary obesity surgery endoluminal(POSE-2) procedure for the treatment of obesity[J]. VideoGIE, 2020, 5(3): 91-93.
|
| [37] |
Deviere J, Ojeda Valdes G, Cuevas Herrera L, et al. Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter study[J]. Surg Endosc, 2008, 22(3): 589-598.
|
| [38] |
Verlaan T, Paulus GF, Mathus-Vliegen EM, et al. Endoscopic gastric volume reduction with a novel articulating plication device is safe and effective in the treatment of obesity(with video)[J]. Gastrointest Endosc, 2015, 81(2): 312-320.
|
| [39] |
Biertho L, Hould FS, Lebel S, et al. Transoral endoscopic restrictive implant system: a new endoscopic technique for the treatment of obesity[J]. Surg Obes Relat Dis, 2010, 6(2): 203-205.
|
| [40] |
McCarty TR, Thompson CC. The current state of bariatric endoscopy[J]. Dig Endosc, 2021, 33(3): 321-334.
|
| [41] |
Igi WF, de Oliveira VL, Matar A, et al. Role of endoscopic duodenojejunal bypass liner in obesity management and glycemic control[J]. Clin Endosc, 2024, 57(3): 309-316.
|
| [42] |
Schouten R, Rijs CS, Bouvy ND, et al. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery[J]. Ann Surg, 2010, 251(2): 236-243.
|
| [43] |
Jirapinyo P, Haas AV, Thompson CC. Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes[J]. Diabetes Care, 2018, 41(5): 1106-1115.
|
| [44] |
Zechmeister-Koss I, Huic M, Fischer S, et al. The duodenal-jejunal bypass liner for the treatment of type 2 diabetes mellitus and/or obesity: a systematic review[J]. Obes Surg, 2014, 24(2): 310-323.
|
| [45] |
Maggi U, Formiga A, Lauro R. Hepatic abscess as a complication of duodenal-jejunal bypass sleeve system and review of the literature[J]. Surg Obes Relat Dis, 2016, 12(5): e47-e50.
|
| [46] |
Ryder REJ, Laubner K, Benes M, et al. Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1, 022 Patients Treated Worldwide[J]. Diabetes Care, 2023, 46(4): e89-e91.
|
| [47] |
Hoyt JA, Cozzi E, D'Alessio DA, et al. A look at duodenal mucosal resurfacing: Rationale for targeting the duodenum in type 2 diabetes[J]. Diabetes Obes Metab, 2024, 26(6): 2017-2028.
|
| [48] |
van Baar ACG, Holleman F, Crenier L, et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study[J]. Gut, 2020, 69(2): 295-303.
|
| [49] |
Sullivan S, Stein R, Jonnalagadda S, et al. Aspiration therapy leads to weight loss in obese subjects: a pilot study[J]. Gastroenterology, 2013, 145(6): 1245-1252.e1-e5.
|
| [50] |
Thompson CC, Abu Dayyeh BK, Kushnir V, et al. Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial[J]. Surg Obes Relat Dis, 2019, 15(8): 1348-1354.
|
| [51] |
Gagner M, Fried M, Michalsky D, et al. First-in-Human Linear Magnetic Jejuno-Ileal Bipartition: Preliminary Results with Incisionless, Sutureless, Swallowable Technique[J]. Obes Surg, 2025, 35(6): 2067-2080.
|
| [52] |
Graves CE, Co C, Hsi RS, et al. Magnetic Compression Anastomosis (Magnamosis): First-In-Human Trial[J]. J Am Coll Surg, 2017, 225(5): 676-681 e671.
|
| [53] |
Foschi D, Corsi F, Lazzaroni M, et al. Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study[J]. Int J Obes(Lond), 2007, 31(4): 707-712.
|
| [54] |
Li L, Liu QS, Liu WH, et al. Treatment of obesity by endoscopic gastric intramural injection of botulinum toxin A: a randomized clinical trial[J]. Hepatogastroenterology, 2012, 59(118): 2003-2007.
|
| [55] |
Liu J, Hou X, Song G, et al. Gastric electrical stimulation using endoscopically placed mucosal electrodes reduces food intake in humans[J]. Am J Gastroenterol, 2006, 101(4): 798-803.
|
| [56] |
Giurgius M, Fearing N, Weir A, et al. Long-term follow-up evaluation of endoscopic sclerotherapy for dilated gastrojejunostomy after gastric bypass[J]. Surg Endosc, 2014, 28(5): 1454-1459.
|